In contrast, patients with EGFR-positive lung adenocarcinoma tended to present with GGO, and patients with KRAS-positive lung adenocarcinoma tended to present with a solid tumor that had limited tendency to metastasize to the lung and pleura. This evidence concerns the gene KRAS and lung adenocarcinoma.